Sweden · Delayed Price · Currency is SEK SpectraCure AB Statistics
Total Valuation
SpectraCure AB has a market cap or net worth of SEK 13.52 million. The enterprise value is 14.80 million.
| Market Cap | 13.52M |
| Enterprise Value | 14.80M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SpectraCure AB has 570.60 million shares outstanding. The number of shares has increased by 408.02% in one year.
| Current Share Class | 570.60M |
| Shares Outstanding | 570.60M |
| Shares Change (YoY) | +408.02% |
| Shares Change (QoQ) | +31.70% |
| Owned by Insiders (%) | 6.27% |
| Owned by Institutions (%) | 2.15% |
| Float | 533.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -55.88 |
| PB Ratio | 0.14 |
| P/TBV Ratio | 0.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.10.
| Current Ratio | 0.79 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.28 |
| Interest Coverage | -32.42 |
Financial Efficiency
Return on equity (ROE) is -48.61% and return on invested capital (ROIC) is -28.11%.
| Return on Equity (ROE) | -48.61% |
| Return on Assets (ROA) | -23.72% |
| Return on Invested Capital (ROIC) | -28.11% |
| Return on Capital Employed (ROCE) | -54.38% |
| Weighted Average Cost of Capital (WACC) | 9.84% |
| Revenue Per Employee | -18,615 |
| Profits Per Employee | -4.27M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SpectraCure AB has paid 41,000 in taxes.
| Income Tax | 41,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.44% in the last 52 weeks. The beta is 0.42, so SpectraCure AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -86.44% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 34.26 |
| Average Volume (20 Days) | 9,146,763 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SpectraCure AB had revenue of SEK -242,000 and -55.53 million in losses. Loss per share was -0.07.
| Revenue | -242,000 |
| Gross Profit | 12.09M |
| Operating Income | -54.28M |
| Pretax Income | -55.49M |
| Net Income | -55.53M |
| EBITDA | -53.98M |
| EBIT | -54.28M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 7.63 million in cash and 8.91 million in debt, with a net cash position of -1.28 million or -0.00 per share.
| Cash & Cash Equivalents | 7.63M |
| Total Debt | 8.91M |
| Net Cash | -1.28M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 93.58M |
| Book Value Per Share | 0.14 |
| Working Capital | -2.69M |
Cash Flow
In the last 12 months, operating cash flow was -32.14 million and capital expenditures -134,000, giving a free cash flow of -32.28 million.
| Operating Cash Flow | -32.14M |
| Capital Expenditures | -134,000 |
| Depreciation & Amortization | 298,000 |
| Net Borrowing | -18.11M |
| Free Cash Flow | -32.28M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | 22,428.51% |
| Pretax Margin | 22,928.93% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SpectraCure AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -408.02% |
| Shareholder Yield | -408.02% |
| Earnings Yield | -410.62% |
| FCF Yield | -238.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |